<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="disclosed. Aravinda M de Silva, Department of Microbiology and Immunology," exact="University of North Carolina" post="School of Medicine, Chapel Hill, North Carolina, USA No"/>
 <result pre="Silva, Department of Microbiology and Immunology, University of North Carolina" exact="School of Medicine," post="Chapel Hill, North Carolina, USA No competing interests were"/>
 <result pre="given vaccine 105. With this evidence of declining efficacy, the" exact="World Health Organization" post="(WHO) Scientific Advisory Group of Experts, the Global Advisory"/>
 <result pre="placebos or vaccinated children 112, 113. The DENV4 in the" exact="Sanofi" post="vaccine is genotype II. Genotype I (GI) and genotype"/>
 <result pre="the ability of sera from naïve subjects who received the" exact="National Institutes of Health" post="dengue vaccine (also based on a DENV4 GII envelope)"/>
 <result pre="(85.5%) viruses. The observation that older children who received the" exact="Sanofi" post="vaccine were equally protected against DENV4 GI and GII"/>
 <result pre="vaccine protection of seronegatives? TAK 003 In January 2018, the" exact="Takeda Pharmaceutical Company" post="(Tokyo, Japan) announced the completion of phase 3 trials"/>
 <result pre="is good dengue vaccine news. For nearly 20 years, the" exact="National Institute of Allergy and Infectious Diseases" post="and the Johns Hopkins Bloomberg School of Public Health"/>
 <result pre="the National Institute of Allergy and Infectious Diseases and the" exact="Johns Hopkins Bloomberg School of Public Health" post="have designed and tested dengue vaccine candidates. Some were"/>
 <result pre="Study in Adults Indicates That a Single Dose of the" exact="National Institute of Allergy and Infectious Diseases" post="Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.J"/>
 <result pre="Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by" exact="National Institutes of Health" post="Monovalent Dengue Virus Vaccines.J Infect Dis.2019;220(2):219–27. 10.1093/infdis/jiz10930895307 143LopesTRRSilvaCSPastorAFet al.:"/>
</results>
